$0.525000
0.00170.32%
Pre-Market: 5:01 AM EDT
15 minutes delayed
Comments
Loading...
BriaCell Therapeutics (NASDAQ:BCTX) Stock, Earnings Estimates, EPS, And Revenue
BriaCell Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Oct 23
EPS Estimate
$-0.460
Quarterly Revenue Estimate
–
Annual Revenue
(as of Apr 30)
(as of Apr 30)
–
Analyze the earnings history of BriaCell Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
BriaCell Therapeutics (BCTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-06-14 | $0.11 | $-0.55 | 120.0 % |
| Dec 2023 | 2024-03-18 | $-0.71 | $-0.20 | -255.0 % |
| Mar 2023 | 2023-06-14 | $-0.32 | $-0.47 | 31.9 % |
| Dec 2022 | 2023-03-16 | $-0.77 | $-0.37 | -108.1 % |
BriaCell Therapeutics (BCTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is BriaCell Therapeutics (NASDAQ:BCTX) reporting earnings?
BriaCell Therapeutics (BCTX) is scheduled to report earnings on December 12, 2024. The last reported earnings were for reported on June 14, 2024 for Q3.
What were the latest earnings per share (EPS) for BriaCell Therapeutics (NASDAQ:BCTX)?
The Actual EPS was $0.11, which beat the estimate of $-0.55.
What were BriaCell Therapeutics’s (NASDAQ:BCTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.